Section one: Contracting authority
one.1) Name and addresses
NHS Blood & Transplant
North Bristol Park
Filton, Bristol
BS34 7QH
marta.drozdzowska@nhsbt.nhs.uk
Country
United Kingdom
NUTS code
UK - UNITED KINGDOM
Internet address(es)
Main address
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
Tenders or requests to participate must be submitted to the above-mentioned address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Support of existing NHSBT Extracorporeal Photopheresis (ECP) systems
Reference number
NHSBT1366
two.1.2) Main CPV code
- 33140000 - Medical consumables
two.1.3) Type of contract
Supplies
two.1.4) Short description
The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Included in the TAS portfolio of therapeutic procedures is Extracorporeal Photopheresis (ECP) which is provided from four of the TAS hub units (Bristol, London, Oxford, and Manchester) as well as all three of the spoke sites (the Clatterbridge Cancer Centre, Cardiff and The Vale Health Board and Plymouth University Hospitals Trust). The ECP system’s utilised by the TAS teams are able to perform both adult and paediatric procedures and have an integral clinical grade light box.
The requirement for this procurement is to source machine consumables and maintenance services to support existing Extracorporeal Photopheresis machine platforms.
This Framework Agreement is for a period of 2 years with two 1-year options to extend. It is the intension of NHSBT to award a Framework Agreement for these requirements by August 2021. The following contracting authorities will be able to purchase against the Framework Agreement: any NHS Authority or Trust and Scottish National Blood Transfusion Service.
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 33693000 - Other therapeutic products
- 50421000 - Repair and maintenance services of medical equipment
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Included in the TAS portfolio of therapeutic procedures is Extracorporeal Photopheresis (ECP) which is provided from four of the TAS hub units (Bristol, London, Oxford, and Manchester) as well as all three of the spoke sites (the Clatterbridge Cancer Centre, Cardiff and The Vale Health Board and Plymouth University Hospitals Trust). The ECP system’s utilised by the TAS teams are able to perform both adult and paediatric procedures and have an integral clinical grade light box.
The requirement for this procurement is to source machine consumables and maintenance services to support existing Extracorporeal Photopheresis machine platforms.
This Framework Agreement is for a period of 2 years with two 1-year options to extend. It is the intension of NHSBT to award a Framework Agreement for these requirements by August 2021. The following contracting authorities will be able to purchase against the Framework Agreement: any NHS Authority or Trust and Scottish National Blood Transfusion Service.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
24
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2020/S 230-568414
four.2.2) Time limit for receipt of tenders or requests to participate
Date
13 April 2021
Local time
5:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.7) Conditions for opening of tenders
Date
13 April 2021
Local time
5:01pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.4) Procedures for review
six.4.1) Review body
NHSBT
Bristol
Country
United Kingdom